You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-1101-ESGO Prediction of incomplete cytoreduction in primary debulking surgery of advanced stage ovarian cancer patients: Usefulness of the entire peritoneal cancer index (PCI) versus exclusive assessment of small intestine/mesentery/hepatoduodena…

Citation Tools

Article menu

Download PDFPDF

Ovarian cancer
2022-RA-1101-ESGO Prediction of incomplete cytoreduction in primary debulking surgery of advanced stage ovarian cancer patients: Usefulness of the entire peritoneal cancer index (PCI) versus exclusive assessment of small intestine/mesentery/hepatoduodenal ligament carcinosis
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Goerdt CE, Bokhua D, Auletta V, et al
2022-RA-1101-ESGO Prediction of incomplete cytoreduction in primary debulking surgery of advanced stage ovarian cancer patients: Usefulness of the entire peritoneal cancer index (PCI) versus exclusive assessment of small intestine/mesentery/hepatoduodenal ligament carcinosis
International Journal of Gynecologic Cancer 2022;32:A298.